PEPTIDE RESEARCH TOPIC

HCG

Explore HCG hormone research, chorionic gonadotropin biology, approved product indications, evidence limitations, and differences from HGH.

TOPIC OVERVIEW

About HCG

Identity and scope

Human chorionic gonadotropin (hCG) is a glycoprotein hormone made of alpha and beta subunits. It is distinct from human growth hormone (HGH) and from short synthetic research peptides.

Key distinctions

Urinary-derived chorionic gonadotropin and recombinant choriogonadotropin alfa are product-specific forms. Their labeling, preparation, and approved indications must be considered separately.

Evidence to examine

HCG acts through the luteinizing-hormone/choriogonadotropin receptor and is involved in gonadal hormone signaling. Its role in pregnancy testing is a biomarker use, distinct from an administered intervention.

How to use this topic

Clinical evidence includes reproductive and endocrine settings. Registry counts on this page require an explicitly named hCG intervention; studies that only measure pregnancy hCG or other biomarkers are not counted as administered-hCG research.

Limits and interpretation

Prescription hCG products have specific labeled indications. The PREGNYL label states that hCG has not been demonstrated effective as an adjunct for obesity treatment. Product approval does not extend to every vendor vial or wellness claim.

Topics covered
  • HCG research
  • human chorionic gonadotropin
  • HCG vs HGH
  • gonadotropin
  • hormone evidence
Common names and related terms: HCG, hCG, Human chorionic gonadotropin, Chorionic gonadotropin
RESEARCH SUMMARY

What Is HCG?

LAST VERIFIEDOctober 7, 2026

HCG is a glycoprotein gonadotropin with alpha and beta subunits. The PREGNYL label describes luteinizing-hormone-like activity and specific reproductive and endocrine indications. These statements concern the labeled product, not all preparations sold under an HCG name. PREGNYL prescribing information, DailyMed

HCG should not be presented as an established weight-loss compound. PREGNYL labeling specifically rejects demonstrated benefit as an adjunct to obesity treatment and distinguishes its approved indications from weight-loss claims. PREGNYL indications and limitations

RESEARCH TRACKER

HCG Development & Clinical Research

Current programs, research areas, study status, enrollment, and expected completion dates organized from primary registry records.

LAST VERIFIEDOctober 7, 2026
Registered records218
Active studies22
Completed studies113
Phase 3 studies47
DeveloperRegistry sponsors include Al-Azhar University, University of Novi Sad, Kristine Loessl. Sponsor identity does not establish product approval.
AliasesHCG, hCG, Human chorionic gonadotropin, Chorionic gonadotropin
Biological targetsHCG acts through the luteinizing-hormone/choriogonadotropin receptor and is involved in gonadal hormone signaling. Its role in pregnancy testing is a biomarker use, distinct from an administered intervention.
Development stageRegistered intervention phases: Early Phase 1, Phase 1, Phase 1 / Phase 2, Phase 2, Phase 2 / Phase 3, Phase 3, Phase 4. See study-specific context.
Regulatory statusPrescription hCG products have specific labeled indications. The PREGNYL label states that hCG has not been demonstrated effective as an adjunct for obesity treatment. Product approval does not extend to every vendor vial or wellness claim.

What current projects are studying

InfertilityPolycystic Ovary SyndromeIn Vitro FertilizationInfertility, FemaleOvulation InductionHypogonadotropic HypogonadismHypogonadism
SELECTED CURRENT RESEARCH

Latest and important projects

Showing 5 of 22 active studies
REGISTERED STUDYNCT07861399

Dual Trigger VS HCG Trigger for Final Oocyte Maturation in Normal Responders

ICSI · IVF · Normal Responders · Infertility Assisted Reproductive Technology · Infertile Women Undergoing IVF or ICSI · Infertile Women Undergoing ART · Triggering Ovulation · Oocyte Maturation

Phase
Not reported
Status
Recruiting
Enrollment
100 Estimated
Expected completion
Oct 2028
Record updated
Oct 6, 2026
Lead sponsor
Al-Azhar University
REGISTERED STUDYNCT07425990

FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles

Infertility Female · Frozen Embryo Transfer (FET)

Phase
Not reported
Status
Recruiting
Enrollment
120 Estimated
Expected completion
Mar 2027
Record updated
Sep 29, 2026
Lead sponsor
University of Novi Sad
REGISTERED STUDYNCT07108621

hCG Priming in Women With Diminished Ovarian Reserve

Infertility, Female · Ovarian Reserve · In Vitro Fertilization (IVF)

Phase
Phase 3
Status
Recruiting
Enrollment
80 Estimated
Expected completion
Mar 31, 2031
Record updated
Sep 21, 2026
Lead sponsor
Kristine Loessl
REGISTERED STUDYNCT07816562

Ovulation Trigger Strategies in Low Ovarian Reserve (TRIGGERBEST)

Low Ovarian Reserve · Poor Ovarian Response

Phase
Phase 3
Status
Recruiting
Enrollment
126 Estimated
Expected completion
Jan 1, 2028
Record updated
Sep 11, 2026
Lead sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
REGISTERED STUDYNCT07340827

A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)

Infertility

Phase
Phase 3
Status
Recruiting
Enrollment
266 Estimated
Expected completion
Jul 5, 2028
Record updated
Sep 8, 2026
Lead sponsor
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Primary sources: ClinicalTrials.gov (defined search)Checked October 7, 2026. Counts include interventional registry records with an explicit matching intervention name or alias; broad search results, biomarker-only observations, and unrelated compounds are excluded. Active includes recruiting, not yet recruiting, active not recruiting, and enrolling by invitation. PubMed is the linked title/abstract query count, not a number of clinical trials or a measure of evidence quality.

Registry status does not establish safety, efficacy, or regulatory approval.

START HERE

Essential HCG guides

HCG KNOWLEDGE ARTICLESPage 1 of 1
01
KNOWLEDGE ARTICLE

HGH vs HCG: Key Differences, Uses, and Safety

HGH vs HCG explained: these are two different hormones with different receptors, medical uses, and legal status. Compare effects, dosing, and safety.

↗
02
KNOWLEDGE ARTICLE

HCG Peptides Online: What to Know Before You Buy

Looking for hcg peptides online? Learn how hCG is regulated in the US, what online sellers actually offer, and key safety and legal facts to check first.

↗
04
KNOWLEDGE ARTICLE

HCG vs Sermorelin: Key Differences Explained

HCG vs sermorelin: compare how these two injectable peptides differ in mechanism, FDA status, dosing, side effects, and what blood work reveals.

↗
06
KNOWLEDGE ARTICLE

AOD 9604 vs HCG: Key Differences Explained

AOD 9604 vs HCG: compare their purposes, mechanisms, and legal status, plus what US buyers should know before safely choosing either compound.

↗
07
KNOWLEDGE ARTICLE

Research Peptides HCG: What Labs Need to Know

Research peptides HCG explained: what human chorionic gonadotropin is, how labs study it, how to vet a supplier, and why it is not FDA-approved for human use.

↗
08
KNOWLEDGE ARTICLE

HCG Peptide: Uses, Safety, and What to Know

HCG peptide is a hormone-derived compound used in fertility treatment and, off-label, for weight loss. Learn its real uses, legal status, and risks.

↗
10
KNOWLEDGE ARTICLE

Peptide Warehouse HCG: What Buyers Should Know

Peptide warehouse HCG listings raise questions about legality, purity, and dosing. Learn what HCG is, how it's sold, and the safety facts before you buy.

↗